# Abingdon Health Launches US Manufacturing Facility

Abingdon Health USA Inc is launching a new manufacturing facility in Madison, Wisconsin, in July 2026 to support European in vitro diagnostic (IVD) manufacturers seeking to enter or expand in the US market. This dual-site manufacturing approach addresses challenges such as tariff volatility, domestic procurement preferences, and supply chain resilience by enabling European companies to maintain production in Europe while establishing compliant, scalable manufacturing capabilities within the United States.

- This development offers procurement professionals and contractors a strategic opportunity to partner with a US-based CDMO that facilitates tariff insulation and access to US government and commercial procurement channels.
- Agencies and organizations involved in diagnostics procurement may find enhanced supply chain resilience and compliance benefits by engaging with dual-site manufacturing partners.
- Companies should evaluate how this US facility launch impacts sourcing strategies, contract opportunities, and regulatory compliance for diagnostic manufacturing within the US market.

**Jurisdictions:** federal
**Industries:** Healthcare
**Topics:** Contracting Vehicles
**Published:** September 23, 2026

### Government Entities
- Biomedical Advanced Research and Development Authority (BARDA)
- National Institutes of Health (NIH)
- Department of Defense (DoD)

### Vendors
- Abingdon Health (prime contractor)

### Sources
- [What To Look for in a Dual Site / US Diagnostics Manufacturing Partner](https://www.abingdonhealth.com/usa-dual-site-manufacturing-partner-key-characteristics) - Abingdon Health plc